Project Code


Research team



Co - Researcher


Project Details

Project Status

Completed - 100%

Viewer: 156

Publish date26 June 2020 10:56

Project Summary

This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymakers and international donors.

Indonesia was selected as a pilot country for the international Decision Support Initiative (iDSI) demonstration project. The pilot project is to focus on building HTA capacity in Indonesia as well as for the Access and Delivery Project (ADP) of PATH International. In this effort the local team from Indonesia’s Health Technology Assessment Committee (HTAC) were to carry out the following evaluations:

  • Economic evaluation of Sildenafil for the treatment of pulmonary arterial hypertension (PAH).
  • Economic evaluation of continuous ambulatory peritoneal dialysis (CAPD) versus hemodialysis (HD) for terminal stage renal disease.
  • These studies are expected to help inform the development of HTA and Indonesia’s HTA National Implementation Plan for the next 5-10 Years. The National Implementation plan is to become a roadmap that emphasizes the following areas of work: curative health, public health needs, facilitating access of health technology to both public and curative health, and optimizing the use of safe, rational health technologies.

    Project’s Aims

    The Indonesia pilot project under iDSI aims to provide policymakers with coordinated support in priority setting as a means to achieve Universal Health Coverage (UHC). The project also aims to institutionalize HTA organizations in Indonesia.

    Project’s Output

  • Economic Evaluations of Sildenafil for the treatment of pulmonary arterial hypertension (PAH)
  • Health Technology Assessment for Renal Dialysis for End-Stage Renal Disease in Indonesia
  • Policy Brief: Off-label medicine; Rational/irrational
  • Documents